<DOC>
	<DOCNO>NCT00485628</DOCNO>
	<brief_summary>Evaluate safety efficacy atomoxetine Japanese pediatric patient ADHD .</brief_summary>
	<brief_title>Safety Study Outpatient Japanese Children With ADHD</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Patients must 6 18 year age Patients must meet DSMIV diagnostic criterion ADHD Patient must able swallow capsule Patients must normal intelligence Laboratory result must show significant abnormality Patients weigh less 15 kg 75 kg study entry Patients document history bipolar disorder history psychosis Patients take antipsychotic medication within 26 week visit 1 Patients severe history allergy Patients take methylphenidate</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>